Shopping Cart
- Remove All
Your shopping cart is currently empty
Eliprodil (SL-820715)(SL-820715), a non-competitive NR2B-NMDA receptor antagonist(IC50: 1 uM), less effective for NR2A- and NR2C-containing receptors(IC50> 100 uM). It has been used in trials studying the treatment of Parkinson Disease and Movement Disorders.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | $33 | In Stock | |
| 25 mg | $64 | In Stock | |
| 50 mg | $119 | In Stock | |
| 100 mg | $178 | In Stock | |
| 500 mg | $427 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $29 | In Stock |
| Description | Eliprodil (SL-820715)(SL-820715), a non-competitive NR2B-NMDA receptor antagonist(IC50: 1 uM), less effective for NR2A- and NR2C-containing receptors(IC50> 100 uM). It has been used in trials studying the treatment of Parkinson Disease and Movement Disorders. |
| Targets&IC50 | NR2B-NMDA:1 μM |
| Synonyms | SL-820715 |
| Molecular Weight | 347.85 |
| Formula | C20H23ClFNO |
| Cas No. | 119431-25-3 |
| Smiles | OC(CN1CCC(Cc2ccc(F)cc2)CC1)c1ccc(Cl)cc1 |
| Relative Density. | 1.205 g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | DMSO: 6 mg/mL (17.25 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.